T. Rowe Price Associates’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $125K | Buy |
|
|||||
|
2025
Q4 | $333K | Hold |
|
|||||
|
2025
Q3 | $336K | Buy |
|
|||||
|
2025
Q2 | $187K | Buy |
|
|||||
|
2025
Q1 | $202K | Buy |
|
|||||
|
2024
Q4 | $161K | Sell |
|
|||||
|
2024
Q3 | $300K | Buy |
|
|||||
|
2024
Q2 | $161K | Buy |
|
|||||
|
2024
Q1 | $158K | Buy |
|
|||||
|
2023
Q4 | $158K | Buy |
|
|||||
|
2023
Q3 | $267K | Buy |
|
|||||
|
2023
Q2 | $329K | Sell |
|
|||||
|
2023
Q1 | $493K | Hold |
|
|||||
|
2022
Q4 | $345K | Buy |
|
|||||
|
2022
Q3 | $184K | Sell |
|
|||||
|
2022
Q2 | $181K | Sell |
|
|||||
|
2022
Q1 | $206K | Buy |
|
|||||
|
2021
Q4 | $148K | Buy |
|
|||||
|
2021
Q3 | $98K | Sell |
|
|||||
|
2021
Q2 | $128K | Buy |
|